Cell and viral regulatory elements enhance the expression and function of a human immunodeficiency virus inhibitory gene

Journal of Virology

Volumn 71, Issue 9, 1997, Pages 7020-7029

  Ranga, Udaykumar ^a   Woffendin, Clive ^a,b   Yang, Zhi Yong ^a,b   Ling, X U ^a   Verma, Sunita ^a   Littman, Dan R ^b,c   Nabel, Gary J ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; REGULATOR PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CYTOMEGALOVIRUS; ENHANCER REGION; EXPRESSION VECTOR; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0030860481     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.9.7020-7029.1997     Document Type: Article

References (73)

1. + hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture. J. Virol. 70:4352-4360.
2. Bahner, I., C. Zhou, X. Yu, Q, Hao, J. C. Guatelli, and D. B. Kohn. 1993. Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes. J. Virol. 67:3199-3207.
3. Berkhout, B., and K. Jeang. 1992. Functional roles for the TATA promoter and enhancers in basal and tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 66:139-149.
4. Bevec, D., M. Dobrovnik, J. Hauber, and E. Bohnlein. 1992. Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev transactivator. Proc. Natl. Acad. Sci. USA 89:9870-9874.
5. + T lymphocytes. Hum. Gene Ther. 5:193-201.
6. Bushart, M., F. Weber, G. Jahn, K. Dorsch-Hasler, B. Fleckenstein, and W. Schaffner. 1985. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521-530.
7. Bowen, D. L., H. C. Lane, and A. S. Fauci. 1985. Immunopathogenesis of the acquired immunodeficiency syndrome. Ann. Intern. Mod. 103:704-709.
8. Buchman, A. R., and P. Berg. 1988. Comparison of intron-dependent and intron-independent gene expression. Mol. Cell. Biol. 8:4395-4405.
9. Bunnell, B. A., L. M. Muul, R. E. Donahue, R. M. Blaese, and R. A. Morgan. 1995. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 92:7739-7743.
10. + cells harboring a human immunodeficiency virus-inducible suicide gene prevents viral spread in an infected cell population. Proc. Natl. Acad. Sci. USA 89:182-180.
11. Chapman, B. S., R. M. Thayer, K. A. Vincent, and N. L. Haigwood. 1991. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res. 19:3979-3986.
12. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
13. Curiel, T. J., D. R. Cook, Y. Wang, B. H. Hahn, S. K. Ghosh, and G. S. Harrison. 1993. Long-term inhibition of clinical and laboratory human immunodeficiency virus strains in human T-cell lines containing an HIV-regulated diphtheria toxin A chain gene. Hum. Gene Ther. 4:741-747.
14. Dalgleish, A. G., P. C. Beverley, P. R. Clapham, D. H. Crawford, M. F. Greaves, and R. A. Weiss. 1984. The CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763-767.
15. Duan, L., O. Bagasra, M. A. Laughlin, J. W. Oakes, and R. J. Pomerantz. 1994. Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody. Proc. Natl. Acad. Sc. USA 91:5075-5079.
16. Escaich, S., C. Kalfoglou, I. Plavec, S. Kaushal, J. D. Mosca, and E. Bohnlein. 1995. Rev M10-mediated inhibition of HIV-1 replication in chronically infected T cells. Hum. Gene Ther. 6:625-634.
17. Fauci, A. S. 1988. The human immunodeficiency virus: infectivity and mech- anisms of pathogenesis. Science 239:617-622.
18. Feinberg, M. B., R. F. Jarrett, A. Aldovini, R. C. Gallo, and F. Wong-Staal. 1986. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 46:807-817.
19. Fox, B. A., C. Woffendin, Z. Y. Yang, H. San, U. Ranga, D. Gordon, J. Osterholzer, and G. J. Nabel. 1995. Genetic modification of human peripheral blood lymphocytes with a transdominant negative form of Rev: safety and toxicity. Hum. Gene Ther. 6:997-1004
20. Ghazal, P., H. Lubon, B. Fleckenstein, and L. Hennighausen. 1987. Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer. Proc. Natl. Acad. Sci. USA 84:3658-3662.
21. Goodbourn, S. 1994. T-cell activation: transcriptional regulation in activated T cells. Curr. Biol. 4:930-932.
22. Grosschedl, R., and D. Baltimore. 1985. Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements. Cell 41:885-897.
23. Harada, S., Y. Koyanagi, H. Nakashima, N. Kobayashi, and N. Yamamoto. 1986. Tumor promoter, TPA, enhances replication of HTLV-III/LAV. Virology 154:249-258.
24. Harrison, G. S., C. J. Long, T. J. Curiel, F. Maxwell, and I. H. Maxwell. 1992. Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene. Hum. Gene Ther. 3:461-469.
25. Hoxie, J. A., J. D. Alpers, J. L. Rackowski, K. Huebner, B. S. Haggerty, A. J. Cedarbaum, and J. C. Reed. 1986. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science 234:1123-1127.
26. Huang, L. and K. Jeang. 1993. Increased spacing between Sp1 and TATAA renders human immunodeficiency virus type 1 replication defective: implication for Tat function. J. Virol. 67:6937-6944.
27. Huang, M. T., and C. M. Gorman. 1990. Intervening sequences increase efficiency of RNA 3′ processing and accumulation of cytoplasmic RNA. Nucleic Acids Res. 18:937-947.
28. Jamieson, C., P. G. McCaffrey, A. Rao, and R. Sen. 1991. Physiologic activation of T cells via the T cell receptor induces NF-KB. J. Immunol. 147: 416-420.
29. Kessinger, A. 1995. Circulating stem cells-waxing hematopoietic. N. Engl. J. Med. 333:315-316.
30. Killeen, N., S. Sawada, and D. R. Littman. 1993. Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. EMBO J. 12:1547-1553.
31. Lee, T. C., B. A. Sullenger, H. F. Gallardo, G. E. Ungers, and E. Gilboa. 1992. Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells. New Biol. 4:66-74.
32. Lemob, D., A. Angeretti, P. Foresta, G. Gribaudo, M. Gariglio, and S. Landolfo. 1994. Trans-activation of the mouse cytomegalovirus immediate early gene enhancer by ras oncogenes. J. Gen. Virol. 75:1685-1692.
33. Liem, S. E., A. Ramezani, X. Li, and S. Joshi. 1993. The development and testing of retroviral vectors expressing transdominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance. Hum. Gene Ther. 4:625-634.
34. Lisziewicz, J., D. Sun, J. Smythe, P. Lusso, F. Lori, A. Louie, P. Markham, J. Rossi, M. Reitz, and R. C. Gallo. 1993. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. Proc. Natl. Acad. Sci. USA 90:8000-8004.
35. Liu, J., C. Woffendin, Z. Yang, and G. J. Nabel. 1994. Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells. Gene Ther. 1:32-37.
36. Malim. M. H., S. Bohnlein, J. Hauber, and B. R. Cullen. 1989. Functional dissection of the HIV-1 Rev trans-activator-derivation of a trans-dominant repressor of Rev function. Cell 58:205-214.
37. Malim, M. H., and B. R. Cullen. 1991. HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell 65:241-248.
38. Malim, M. H., W. W. Freimuth, J. Liu, T. J. Boyle, H. K. Lylerly, B. R. Cullen, and G. J. Nabel. 1992. Stable expression of transdominant rev protein in human T cells inhibits human immunodeficiency virus replication. J. Exp. Med. 176:1197-1201.
39. Malim, M. H., J. Hauber, R. Fenrick, and B. R. Cullen. 1988. Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes, Nature 335:181-183.
40. Malim, M. H., D. F. McCarn, L. S. Tiley, and B. R. Cullen. 1991. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J. Virol. 65:4248-4254.
41. Marasco, W. A., W. A. Haseltine, and S. Y. Chen. 1993. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc. Natl. Acad. Sci. USA 90:7889-7893.
42. Markovitz, D. M., M. Hannibal, V. L. Perez. C. Gauntt, T. M. Folks, and G. J. Nabel. 1990. Differential regulation of human immunodeficiency viruses: a novel HIV-2 regulatory element responds to stimulation of the T-cell antigen receptor. Proc. Natl. Acad. Sci, USA 87:9098-9102.
43. Mhashilkar, A. M., J. Bagley, S. Y. Chen, A. M. Szilvay, D. G. Helland, and W. A. Marasco. 1995. Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies. EMBO J. 14:1542-1551.
44. Modesti, N., J. Garcia, C. Debouck, M. Peterlin, and R. Gaynor. 1991. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression. New Biol. 3:759-768.
45. Muesing, M., D. H. Smith, and D. J. Capon. 1987.Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 48:691-701.
46. Nabel, G. J., B. A. Fox, L. Post, C. B. Thompson, and C. Woffendin. 1994. Clinical protocol: a molecular genetic intervention for AIDS-effects of a transdominant negative form of Rev. Hum. Gene Ther. 5:79-92.
47. Ojwang, J. O., A. Hampel, D. J. Looney, F. Wong-Staal, and J. Rappaport. 1992. Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme. Proc. Natl. Acad. Sci. USA 89:10802-10806.
48. Pearson, L., J. Garcia, F. Wu, N. Modesti, J. Nelson, and R. Gaynor. 1990. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat. Proc. Natl. Acad. Sci, USA 87:5079-5083.
49. Pomerantz, R, J., D. Trono, M. B. Feinberg, and D. Baltimore. 1990. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61:1271-1276.
50. Rosen, C. A., J. G. Sodroski, and W. A. Haseltine. 1985. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 41:813-823.
51. Rosenberg, S. A., P. Aebersold, K. Cornetta, A. Kasid, R. A. Morgan, R. Moen, E. M. Karson, M. T. Lotze, J. C. Yang, S. L. Topalian, M. J. Merino, K. Culver, A. D. Miller, R. M. Blaese, and W. F. Anderson. 1990. Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 323:570-578.
52. Salmons, B., and W. H. Gunzburg. 1993. Targeting of retroviral vectors for gene therapy. Hum. Gene Ther. 4:129-141.
53. Sambrook, J., E. F. Fritch, and T. Maniatis. Molecular cloning: a laboratory manual, 2nd ed. 1994. Cold Spring Laboratory Harbor Press, Cold Spring Harbor, N.Y.
54. Sambucetti, L. C., J. M. Cherrington, G. W. G. Wilkinson, and E. S. Mocarski. 1989. NF-kappaB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 8:4251-4258.
55. Sarver, N., E. M. Cantin, P. S. Chang, J. A. Zaia, P. A. Ladne, D. A. Stephens, and J. J. Rossi. 1990. Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247:1222-1225.
56. Sawada, S., and D. R. Littman. 1991. Identification and characterization of a T-cell-specific enhancer adjacent to the murine CD4 gene. Mol. Cell. Biol. 11:5506-5515.
57. Sawada, S., and D. R. Littman. 1993. A heterodimer of HEB and an E12related protein interacts with the CD4 enhancer and regulates its activity in T-cell lines. Mol. Cell. Biol. 13:5620-5628.
58. Selby, M. J., E. S. Bain, P. A. Luciw, and B. M. Peterlin. 1989. Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Genes Dev. 3:547-558.
59. Siu, G., A. L. Wurster, J, S. Lipsick, and S. M. Hedríck. 1992. Expression of the CD4gene requires a Myb transcription factor. Mol. Cell. Biol. 12:1592-1604.
60. Sodroski, J., W. C. Goh, C. Rosen, A. Dayton, E. Terwilliger, and W. Haseltine. 1986. A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature 321:412-417.
61. Southgate, C. D., and M. R. Green. 1991. The HIV-1 Tat protein activates transcription from an upstream DNA-binding sìte: implications for Tat function. Genes Dev. 5:2496-2507.
62. Spangrude, G. J., S. Heimfeld, and I. L. Weissman. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241:58-62.
63. Sullenger, B. A., H. F. Gallardo, G. E. Ungers, and E. Gilboa. 1990. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63:601-608.
64. Sweet, R. W., A. Truneh, and W. A. Hendrickson. 1991. CD4: its structure, role in immune function and AIDS pathogenesis, and potential as a pharmacological target. Curr. Opin. Biotechnol. 2:622-633.
65. Trono, D., M. Feinberg, and D. Baltimore. 1989. HIV-1 gag mutants can dominantly interfere with the replication of the wild type virus. Cell 59:113-120.
66. Van Ooyen, A., J, Van Den Berg, N. Mantel, and C. Weissmann. 1979. Comparison of total sequence of a cloned rabbit β-globin gene and its flanking regions with a homologous mouse sequence. Science 206:337-344.
67. + T lymphocytes by retroviral vectors expressing anti-HIV genes. J Virol 69:4045-4052.
68. Venkatesh, L. K., and G. Chinnadurai. 1990. Mutants in a conserved region near the carboxy-terminus of HIV-1 Rev identify functionally important residues and exhibit a dominant negative phenotype. Virology 178:327-330.
69. Woffendin, C., U. Ranga, Z. Yang, L. Xu, and G. J. Nabel. 1996. Expression of a protective gene prolongs survival of T cells in human immunodeficiency virus-infected patients, Proc. Natl. Acad. Sci. USA 93:2889-2894.
70. Woffendin, C., Z. Yang, Udaykumar, L. Xu, N. Yang, M. J. Sheeny, and G. J. Nabel. 1994. Non-viral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells. Proc. Natl. Acad. Sci. USA 91:11581-11585.
71. Yu, M., J. Ojwang, O. Yamada, A. Hampel, J. Rapapport, D. Looney, and F. Wong-Staal. 1993. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90: 6340-6344.
72. Zagury, D., J. Bernard, R. Leonard, R. Cheynier, M. Fledman, P. S. Sarin, and R. C, Gallo. 1986. Long-term cultures of HTLV-III-infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science 231:850-853.
73. Zhou, C., I. C. Bahner, G. P. Larso, J. A. Zaia, J. J. Rossi, and D. B. Kohn. 1994. Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Gene 149:33-39.